Recent advances in our understanding of insulin signalling to the podocyte

Nephrology Dialysis Transplantation

Volumn 29, Issue 6, 2014, Pages 1127-1133

  Lay, Abigail ^a   Coward, Richard J ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

AKT; diabetic nephropathy; insulin; podocyte

Indexed keywords

INSULIN;

CELL ACTIVITY; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; GLOMERULONEPHRITIS; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; PODOCYTE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

AKT; DIABETIC NEPHROPATHY; INSULIN; PODOCYTE;

ANIMALS; DIABETIC NEPHROPATHIES; HUMANS; HYPERGLYCEMIA; INFLAMMATION; INSULIN; INSULIN RESISTANCE; KIDNEY; OBESITY; PODOCYTES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84901814251     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft471     Document Type: Review

References (55)

1. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006; 7: 85-96 (Pubitemid 43278292)
2. Belfiore A, Frasca F, Pandini G et al. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev 2009; 30: 586-623
3. White MF. IRS Proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 2002; 283: E413-E422 (Pubitemid 35230477)
4. George S, Rochford JJ, Wolfrum C et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 2004; 304: 1325-1328 (Pubitemid 38697429)
5. Canaud G, Bienaime F, Viau A et al. AKT2 is essential to maintain podocyte viability and function during chronic kidney disease. Nat Med 2013; 19: 1288-1296
6. Sano H, Kane S, Sano E et al. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem 2003; 278: 14599-14602 (Pubitemid 36799780)
7. Cross DAE, Alessi DR, Cohen P et al. Inhibition of glycogen-synthase kinase-3 by insulin-mediated by protein-kinase-B. Nature 1995; 378: 785-789 (Pubitemid 26004411)
8. Baumann CA, Ribon V, Kanzaki M et al. CAP Defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 2000; 407: 202-207
9. Hale LJ, Coward RJ. Insulin signalling to the kidney in health and disease. Clin Sci 2013; 124: 351-370
10. Tiwari S, Singh RS, Li L et al. Deletion of the insulin receptor in the proximal tubule promotes hyperglycemia. J Am Soc Nephrol 2013; 24: 1209-1214
11. Tiwari S, Halagappa VKM, Riazi S et al. Reduced expression of insulin receptors in the kidneys of insulin-resistant rats. J Am Soc Nephrol 2007; 18: 2661-2671 (Pubitemid 47531193)
12. Mogensen CE, Christensen NJ, Gundersen HJG. The acute effect of insulin on heart-rate, blood-pressure, plasma noradrenaline and urinary albumin excretion - the role of changes in blood-glucose. Diabetologia 1980; 18: 453-457 (Pubitemid 10114468)
13. Mima A, Ohshiro Y, Kitada M et al. Glomerular-specific protein kinase Cbeta- induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity. Kidney Int 2011; 79: 883-896
14. Welsh GI, Hale LJ, Eremina V et al. Insulin signaling to the glomerular podocyte Is critical for normal kidney function. Cell Metab 2010; 12: 329-340
15. Coward RJM, Welsh GI, Yang J et al. The human glomerular podocyte is a novel target for insulin action. Diabetes 2005; 54: 3095-3102 (Pubitemid 43334361)
16. Coward RJM, Welsh GI, Koziell A et al. Nephrin is critical for the action of insulin on human glomerular podocytes. Diabetes 2007; 56: 1127-1135 (Pubitemid 46525068)
17. Hale LJ, Hurcombe J, Lay A et al. Insulin directly stimulates VEGF-A production in the glomerular podocyte. Am J Physiol Renal Physiol 2013; 305: F182-F188
18. Kim EY, Dryer SE. Effects of insulin and high glucose on mobilization of slo1 BKCa channels in podocytes. J Cell Physiol 2011; 226: 2307-2315
19. Kim EY, Anderson M, Dryer SE. Insulin increases surface expression of TRPC6 channels in podocytes: role of NADPH oxidases and reactive oxygen species. Am J Physiol Renal Physiol 2012; 302: F298-F307
20. Saleem MA, Zavadil J, Bailly M et al. The molecular and functional phenotype of glomerular podocytes reveals key features of contractile smooth muscle cells. Am J Physiol Renal Physiol 2008; 295: F959-F970
21. Dryer SE, Reiser J. TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology. Am J Physiol Renal Physiol 2010; 299: F689-F701
22. Piwkowska A, Rogacka D, Kasztan M et al. Insulin increases glomerular filtration barrier permeability through dimerization of protein kinase G type I alpha subunits. Biochim Biophys Acta 2013; 1832: 791-804
23. Bisson N, Ruston J, Jeansson M et al. The adaptor protein Grb2 is not essential for the establishment of the glomerular filtration barrier. PLoS One 2012; 7: e50996
24. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 2004; 88: 787. -+
25. Reaven GM. Role of insulin resistance in human-disease (syndrome-x) - an expanded definition. Annu Rev Med 1993; 44: 121-131 (Pubitemid 23117853)
26. Greenbaum CJ. Insulin resistance in type 1 diabetes. Diabetes Metab Res Rev 2002; 18: 192-200 (Pubitemid 34778382)
27. Hotamisligil GS, Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 2008; 8: 923-934
28. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867 (Pubitemid 46024993)
29. Griffin ME, Marcucci MJ, Cline GW et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999; 48: 1270-1274 (Pubitemid 29241025)
30. Lennon R, Pons D, Sabin MA et al. Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy. Nephrol Dial Transplant 2009; 24: 3288-3296
31. Tejada T, Catanuto P, Ijaz A et al. Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death. Kidney Int 2008; 73: 1385-1393 (Pubitemid 351770481)
32. Yamauchi T, Kamon J, Waki H et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941-946 (Pubitemid 32756432)
33. Sharma K, RamachandraRao S, Qiu G et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 2008; 118: 1645-1656 (Pubitemid 351632369)
34. Rutkowski JM, Wang ZV, Park AS et al. Adiponectin promotes functional recovery after podocyte ablation. J Am Soc Nephrol 2013; 24: 268-282
35. Hyvonen ME, Saurus P, Wasik A et al. Lipid phosphatase SHIP2 downregulates insulin signalling in podocytes. Mol Cell Endocrinol 2010; 328: 70-79
36. Drapeau N, Lizotte F, Denhez B et al. Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes. Am J Physiol Endocrinol Metab 2013; 304: E1188-E1198
37. Navarro-Gonzalez JF, Mora-Fernandez C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 2008; 19: 433-442 (Pubitemid 351355386)
38. Tuttle KR. Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease. J Am Soc Nephrol 2005; 16: 1537-1538 (Pubitemid 41716459)
39. Du P, Fan B, Han H et al. NOD2 Promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy. Kidney Int 2013; 84: 265-276
40. Song MJ, Kim KH, Yoon JM et al. Activation of toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 2006; 346: 739-745
41. Devaraj S, Dasu MR, Rockwood J et al. Increased toll-like receptor (TLR)2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 2008; 93: 578-583 (Pubitemid 351240834)
42. Dasu MR, Devaraj S, Zhao L et al. High glucose induces toll-like receptor expression in human monocytes mechanism of activation. Diabetes 2008; 57: 3090-3098
43. Dasu MR, Jialal I. Free fatty acids in the presence of high glucose amplify monocyte inflammation via toll-like receptors. Am J Physiol Endocrinol Metab 2011; 300: E145-E154
44. Cha JJ, Hyun YY, Lee MH et al. Renal protective effects of toll-like receptor 4 signaling blockade in type 2 diabetic mice. Endocrinology 2013; 154: 2144-2155
45. D'Apolito M, Du XL, Zong HH et al. Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J Clin Invest 2010; 120: 203-213
46. Hers I, Vincent EE, Tavare JM. Akt signalling in health and disease. Cell Signal 2011; 23: 1515-1527
47. Isshiki K, Haneda M, Koya D et al. Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes 2000; 49: 1022-1032 (Pubitemid 30349426)
48. Panchapakesan U, Chen XM, Pollock CA. Drug insight: thiazolidinediones and diabetic nephropathy-relevance to renoprotection. Nat Clin Pract Nephrol 2005; 1: 33-43
49. Sarafidis PA, Bakris GL. Protection of the kidney by thiazolidinediones: an assessment from bench to bedside. Kidney Int 2006; 70: 1223-1233 (Pubitemid 44435173)
50. Ma LJ, Marcantoni C, Linton MF et al. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int 2001; 59: 1899-1910 (Pubitemid 32336806)
51. Yang HC, Deleuze S, Zuo Y et al. The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury. J Am Soc Nephrol 2009; 20: 2380-2388
52. Imano E, Kanda T, Nakatani Y et al. Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy. Diabetes Care 1998; 21: 2135-2139 (Pubitemid 28549163)
53. Nakamura T, Ushiyama C, Osada S et al. Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria. Metabolism 2001; 50: 1193-1196 (Pubitemid 33034703)
54. Nakamura T, Ushiyama C, Shimada N et al. Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients. J Diabetes Complications 2000; 14: 250-254
55. Lennon R,Welsh GI, Singh A et al. Rosiglitazone enhances glucose uptake in glomerular podocytes using the glucose transporter GLUT1. Diabetologia 2009; 52: 1944-1952